Alpha Cognition Inc. Other Nonoperating Expense
Alpha Cognition Inc. (ACOG) reported Other Nonoperating Expense of $11.92 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2026-05-14
- Alpha Cognition Inc. other nonoperating expense for the quarter ending 2026-03-31 was $11.92K, a 1145.45% increase year-over-year.
- Alpha Cognition Inc. other nonoperating expense for the quarter ending 2025-03-31 was $957.00.
- Alpha Cognition Inc. other nonoperating expense for fiscal 2025 was $77.81K, a 67.18% decline from fiscal 2024.
- Alpha Cognition Inc. other nonoperating expense for fiscal 2024 was $237.05K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 12 month |
|---|---|---|
| 2026-03-31 | $11.92K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $77.81K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $957.00 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $237.05K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |